Lilly’s Affordable Zepbound Vials: A Game Changer
Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
- Latest
- Trending
Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
Efficient Capital Labs raises $11M to boost revenue-based financing for SaaS firms in South Asia-U.S. corridor.
NTT DATA boosts performance by aligning HR and Finance on SAP's cloud platform, enhancing agility and reducing complexity.
Genians expands NAC to secure IoT and infrastructure, integrating ZTNA for comprehensive protection against cyber threats.
Aleph Zero launches EVM-compatible layer-2 for faster Web3 apps, boosting privacy tools and transaction speed.
Dogecoin recovers with 6% rise; MoonTaurus presale success positions it for a potential 100x gain by Q4 2024.
Analyst Jamie Coutts identifies a promising scenario for Bitcoin as global liquidity increases, signaling potential market movement.
Mars' acquisition of Kellanova boosts grocery stocks amid inflation and regulatory scrutiny in the food industry.
High-severity vulnerability in Prisma Access Browser fixed. Users urged to update to the latest version for security.
Ivanti patches severe vTM vulnerability CVE-2024-7593, urging updates to prevent unauthorized admin access.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.